To address these new clinical challenges, more efforts are needed to investigate the roles of androgen/AR signaling in both epithelial tumor cells and their niches during current ADT treatments to gain more and deeper insights into the development of new and effective therapeutic strategies for advanced PCa. Here, AR is linked to neoplasm.